Navigating Expectations, Strategies, and Challenges in Vitiligo
Andrew Alexis, MD, MPH; Karan Lal, DO, MS, FAAD; James Song, MD; Lisa Swanson, MD, and Lisa Swanson, MD, address vitiligo management across adult and pediatric populations, examining treatment strategies, psychological support, emerging therapies like JAK inhibitors, and the critical importance of individualized care plans that consider disease characteristics, age-specific needs, and family education.
EP. 2: Anticipating Advances for Pediatric Vitiligo
November 21st 2024The panelist discusses advances in targeted therapies, including novel biologics and small molecules, as well as the development of personalized treatment approaches tailored to individual patient characteristics, which hold great promise for improving outcomes and enhancing the quality of life for children living with vitiligo in the future.
EP. 3: Telehealth and Research Strides for Young Patients
November 21st 2024Lisa Swanson, MD, discusses how telemedicine and digital health tools can aid in the management and follow-up care of pediatric patients with vitiligo by enabling remote monitoring, improving access to specialists, and facilitating patient engagement, while emerging research into vitiligo treatments may focus on developing therapies to halt or slow the progression of this autoimmune skin condition.
